SR 11302

CAS : 160162-42-5

Ref. 3D-KGA16242

Informations sur le produit

• Nom: SR 11302
• Synonymes: 2,4,6,8-Nonatetraenoic acid, 3-methyl-7-(4-methylphenyl)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-

Description

SR 11302 is a chemical inhibitor that inhibits the activation of nuclear factor kappa B (NF-κB), an enzyme that regulates the transcription of genes involved in immune responses, inflammation, and cancer. SR 11302 has been shown to suppress the activity of NF-κB in the mouse liver cells, which was associated with decreased levels of locomotor activity. This drug also inhibited tumor growth in mice by reducing the expression of c-jun and other proteins involved in cell proliferation and differentiation. SR 11302 may be used as a treatment for autoimmune diseases or mucin gene expression disorders such as Crohn's disease or carcinoma.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 376.54 g/mol
• Formule: C₂₆H₃₂O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder